Global Non-Insulin Therapies for Diabetes Market Research Report 2017

Global Non-Insulin Therapies for Diabetes Market Research Report 2017

1 Non-Insulin Therapies for Diabetes Market Overview

1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes

1.2 Non-Insulin Therapies for Diabetes Segment by Type (Product Category)

1.2.1 Global Non-Insulin Therapies for Diabetes Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)

1.2.2 Global Non-Insulin Therapies for Diabetes Production Market Share by Type (Product Category) in 2016

1.2.3 Alpha-glucosidase Inhibitors

1.2.4 Amylin Agonists

1.2.5 Biguanides

1.2.6 Dipeptidyl Peptidase-4 (DPP4) Inhibitors

1.2.7 Glinides / Meglitinides

1.2.8 GLP-1 Analogs / GLP-1 Agonists

1.2.9 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

1.2.10 Sulfonylureas

1.2.11 Thiazolidinediones

1.2.12 Others

1.3 Global Non-Insulin Therapies for Diabetes Segment by Application

1.3.1 Non-Insulin Therapies for Diabetes Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacy

1.3.5 Others

1.4 Global Non-Insulin Therapies for Diabetes Market by Region (2012-2022)

1.4.1 Global Non-Insulin Therapies for Diabetes Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Non-Insulin Therapies for Diabetes (2012-2022)

1.5.1 Global Non-Insulin Therapies for Diabetes Revenue Status and Outlook (2012-2022)

1.5.2 Global Non-Insulin Therapies for Diabetes Capacity, Production Status and Outlook (2012-2022)

2 Global Non-Insulin Therapies for Diabetes Market Competition by Manufacturers

2.1 Global Non-Insulin Therapies for Diabetes Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Non-Insulin Therapies for Diabetes Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Non-Insulin Therapies for Diabetes Production and Share by Manufacturers (2012-2017)

2.2 Global Non-Insulin Therapies for Diabetes Revenue and Share by Manufacturers (2012-2017)

2.3 Global Non-Insulin Therapies for Diabetes Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Non-Insulin Therapies for Diabetes Manufacturing Base Distribution, Sales Area and Product Type

2.5 Non-Insulin Therapies for Diabetes Market Competitive Situation and Trends

2.5.1 Non-Insulin Therapies for Diabetes Market Concentration Rate

2.5.2 Non-Insulin Therapies for Diabetes Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Non-Insulin Therapies for Diabetes Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Non-Insulin Therapies for Diabetes Capacity and Market Share by Region (2012-2017)

3.2 Global Non-Insulin Therapies for Diabetes Production and Market Share by Region (2012-2017)

3.3 Global Non-Insulin Therapies for Diabetes Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Non-Insulin Therapies for Diabetes Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Non-Insulin Therapies for Diabetes Consumption by Region (2012-2017)

4.2 North America Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

4.3 Europe Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

4.4 China Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

4.5 Japan Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

4.7 India Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

5 Global Non-Insulin Therapies for Diabetes Production, Revenue (Value), Price Trend by Type

5.1 Global Non-Insulin Therapies for Diabetes Production and Market Share by Type (2012-2017)

5.2 Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)

5.3 Global Non-Insulin Therapies for Diabetes Price by Type (2012-2017)

5.4 Global Non-Insulin Therapies for Diabetes Production Growth by Type (2012-2017)

6 Global Non-Insulin Therapies for Diabetes Market Analysis by Application

6.1 Global Non-Insulin Therapies for Diabetes Consumption and Market Share by Application (2012-2017)

6.2 Global Non-Insulin Therapies for Diabetes Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Non-Insulin Therapies for Diabetes Manufacturers Profiles/Analysis

7.1 GSK

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 GSK Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 Eli Lilly

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Sumitomo Dainippon Pharma

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Intarcia Therapeutics

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Servier

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Servier Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Jiangsu Hansoh Pharmaceutical

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 Novo Nordisk

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 Emisphere

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Emisphere Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Uni-Bio Science Group

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 Takeda

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Takeda Non-Insulin Therapies for Diabetes Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

7.11 3SBio

7.12 Merck

7.13 Dong-A Pharmaceutical

7.14 Luye Pharma Group

7.15 Eurofarma

7.16 Geropharm

7.17 Alkem Labs

7.18 SatRx

7.19 Pfizer

7.20 Jiangsu Hengrui Medicine

8 Non-Insulin Therapies for Diabetes Manufacturing Cost Analysis

8.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Non-Insulin Therapies for Diabetes Market Forecast (2017-2022)

12.1 Global Non-Insulin Therapies for Diabetes Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Non-Insulin Therapies for Diabetes Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Non-Insulin Therapies for Diabetes Price and Trend Forecast (2017-2022)

12.2 Global Non-Insulin Therapies for Diabetes Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Non-Insulin Therapies for Diabetes Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Non-Insulin Therapies for Diabetes Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

Figure Picture of Non-Insulin Therapies for Diabetes

Figure Global Non-Insulin Therapies for Diabetes Production () and CAGR (%) Comparison by Types (Product Category) (2012-2022)

Figure Global Non-Insulin Therapies for Diabetes Production Market Share by Types (Product Category) in 2016

Figure Product Picture of Alpha-glucosidase Inhibitors

Table Major Manufacturers of Alpha-glucosidase Inhibitors

Figure Product Picture of Amylin Agonists

Table Major Manufacturers of Amylin Agonists

Figure Product Picture of Biguanides

Table Major Manufacturers of Biguanides

Figure Product Picture of Dipeptidyl Peptidase-4 (DPP4) Inhibitors

Table Major Manufacturers of Dipeptidyl Peptidase-4 (DPP4) Inhibitors

Figure Product Picture of Glinides / Meglitinides

Table Major Manufacturers of Glinides / Meglitinides

Figure Product Picture of GLP-1 Analogs / GLP-1 Agonists

Table Major Manufacturers of GLP-1 Analogs / GLP-1 Agonists

Figure Product Picture of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

Table Major Manufacturers of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

Figure Product Picture of Sulfonylureas

Table Major Manufacturers of Sulfonylureas

Figure Product Picture of Thiazolidinediones

Table Major Manufacturers of Thiazolidinediones

Figure Product Picture of Others

Table Major Manufacturers of Others

Figure Global Non-Insulin Therapies for Diabetes Consumption () by Applications (2012-2022)

Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share by Applications in 2016

Figure Hospital Pharmacy Examples

Figure Retail Pharmacies Examples

Figure Online Pharmacy Examples

Figure Others Examples

Figure Global Non-Insulin Therapies for Diabetes Market Size (Million USD), Comparison () and CAGR (%) by Regions (2012-2022)

Figure North America Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Non-Insulin Therapies for Diabetes Revenue (Million USD) Status and Outlook (2012-2022)

Figure Global Non-Insulin Therapies for Diabetes Capacity, Production () Status and Outlook (2012-2022)

Figure Global Non-Insulin Therapies for Diabetes Major Players Product Capacity () (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Capacity () of Key Manufacturers (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Capacity Market Share of Key Manufacturers (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Capacity () of Key Manufacturers in 2016

Figure Global Non-Insulin Therapies for Diabetes Capacity () of Key Manufacturers in 2017

Figure Global Non-Insulin Therapies for Diabetes Major Players Product Production () (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Production () of Key Manufacturers (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Production Share by Manufacturers (2012-2017)

Figure 2016 Non-Insulin Therapies for Diabetes Production Share by Manufacturers

Figure 2017 Non-Insulin Therapies for Diabetes Production Share by Manufacturers

Figure Global Non-Insulin Therapies for Diabetes Major Players Product Revenue (Million USD) (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Revenue (Million USD) by Manufacturers (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers (2012-2017)

Table 2016 Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers

Table 2017 Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers

Table Global Market Non-Insulin Therapies for Diabetes Average Price () of Key Manufacturers (2012-2017)

Figure Global Market Non-Insulin Therapies for Diabetes Average Price () of Key Manufacturers in 2016

Table Manufacturers Non-Insulin Therapies for Diabetes Manufacturing Base Distribution and Sales Area

Table Manufacturers Non-Insulin Therapies for Diabetes Product Category

Figure Non-Insulin Therapies for Diabetes Market Share of Top 3 Manufacturers

Figure Non-Insulin Therapies for Diabetes Market Share of Top 5 Manufacturers

Table Global Non-Insulin Therapies for Diabetes Capacity () by Region (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Capacity Market Share by Region (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Capacity Market Share by Region (2012-2017)

Figure 2016 Global Non-Insulin Therapies for Diabetes Capacity Market Share by Region

Table Global Non-Insulin Therapies for Diabetes Production by Region (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Production () by Region (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Production Market Share by Region (2012-2017)

Figure 2016 Global Non-Insulin Therapies for Diabetes Production Market Share by Region

Table Global Non-Insulin Therapies for Diabetes Revenue (Million USD) by Region (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Revenue Market Share by Region (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Revenue Market Share by Region (2012-2017)

Table 2016 Global Non-Insulin Therapies for Diabetes Revenue Market Share by Region

Figure Global Non-Insulin Therapies for Diabetes Capacity, Production () and Growth Rate (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Table North America Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Table China Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Table Japan Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Table Southeast Asia Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Table India Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Consumption () Market by Region (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Consumption Market Share by Region (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share by Region (2012-2017)

Figure 2016 Global Non-Insulin Therapies for Diabetes Consumption () Market Share by Region

Table North America Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export () (2012-2017)

Table Europe Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export () (2012-2017)

Table China Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export () (2012-2017)

Table Japan Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export () (2012-2017)

Table Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export () (2012-2017)

Table India Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export () (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Production () by Type (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Production Share by Type (2012-2017)

Figure Production Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)

Figure 2016 Production Market Share of Non-Insulin Therapies for Diabetes by Type

Table Global Non-Insulin Therapies for Diabetes Revenue (Million USD) by Type (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)

Figure 2016 Revenue Market Share of Non-Insulin Therapies for Diabetes by Type

Table Global Non-Insulin Therapies for Diabetes Price () by Type (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Production Growth by Type (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Consumption () by Application (2012-2017)

Table Global Non-Insulin Therapies for Diabetes Consumption Market Share by Application (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share by Applications (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share by Application in 2016

Table Global Non-Insulin Therapies for Diabetes Consumption Growth Rate by Application (2012-2017)

Figure Global Non-Insulin Therapies for Diabetes Consumption Growth Rate by Application (2012-2017)

Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GSK Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure GSK Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure GSK Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure GSK Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Eli Lilly Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Eli Lilly Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Eli Lilly Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Intarcia Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Servier Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Servier Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Servier Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Servier Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Servier Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Novo Nordisk Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Novo Nordisk Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Novo Nordisk Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Emisphere Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Emisphere Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Emisphere Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Emisphere Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Emisphere Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Uni-Bio Science Group Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Takeda Non-Insulin Therapies for Diabetes Capacity, Production (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Takeda Non-Insulin Therapies for Diabetes Production Growth Rate (2012-2017)

Figure Takeda Non-Insulin Therapies for Diabetes Production Market Share (2012-2017)

Figure Takeda Non-Insulin Therapies for Diabetes Revenue Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Non-Insulin Therapies for Diabetes

Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

Figure Non-Insulin Therapies for Diabetes Industrial Chain Analysis

Table Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2016

Table Major Buyers of Non-Insulin Therapies for Diabetes

Table Distributors/Traders List

Figure Global Non-Insulin Therapies for Diabetes Capacity, Production () and Growth Rate Forecast (2017-2022)

Figure Global Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Non-Insulin Therapies for Diabetes Price (Million USD) and Trend Forecast (2017-2022)

Table Global Non-Insulin Therapies for Diabetes Production () Forecast by Region (2017-2022)

Figure Global Non-Insulin Therapies for Diabetes Production Market Share Forecast by Region (2017-2022)

Table Global Non-Insulin Therapies for Diabetes Consumption () Forecast by Region (2017-2022)

Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share Forecast by Region (2017-2022)

Figure North America Non-Insulin Therapies for Diabetes Production () and Growth Rate Forecast (2017-2022)

Figure North America Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table North America Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import () Forecast (2017-2022)

Figure Europe Non-Insulin Therapies for Diabetes Production () and Growth Rate Forecast (2017-2022)

Figure Europe Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Europe Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import () Forecast (2017-2022)

Figure China Non-Insulin Therapies for Diabetes Production () and Growth Rate Forecast (2017-2022)

Figure China Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table China Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import () Forecast (2017-2022)

Figure Japan Non-Insulin Therapies for Diabetes Production () and Growth Rate Forecast (2017-2022)

Figure Japan Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Japan Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import () Forecast (2017-2022)

Figure Southeast Asia Non-Insulin Therapies for Diabetes Production () and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import () Forecast (2017-2022)

Figure India Non-Insulin Therapies for Diabetes Production () and Growth Rate Forecast (2017-2022)

Figure India Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table India Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import () Forecast (2017-2022)

Table Global Non-Insulin Therapies for Diabetes Production () Forecast by Type (2017-2022)

Figure Global Non-Insulin Therapies for Diabetes Production () Forecast by Type (2017-2022)

Table Global Non-Insulin Therapies for Diabetes Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Non-Insulin Therapies for Diabetes Revenue Market Share Forecast by Type (2017-2022)

Table Global Non-Insulin Therapies for Diabetes Price Forecast by Type (2017-2022)

Table Global Non-Insulin Therapies for Diabetes Consumption () Forecast by Application (2017-2022)

Figure Global Non-Insulin Therapies for Diabetes Consumption () Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source